Skip to content

ORAGENICS, INC.: 10-K filed 2014-02-28

What ORAGENICS, INC. reported in its annual report filed 2014-02-28 (fiscal FY 2013): 30 published measures, 87 facts as tagged in accession 0001193125-14-077374.

This filing

Form
10-K (annual report)
Filed
2014-02-28
Fiscal period
fiscal FY 2013
Accession
0001193125-14-077374 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ORAGENICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3116,831,482USD
At 2012-12-3110,488,132USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-3115,838,635USD
At 2012-12-319,231,646USD
At 2011-12-31-8,179,318USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3116,276,510USD
At 2012-12-319,925,967USD
At 2011-12-31171,739USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-3,079,335USD92
2013-01-01 to 2013-12-31-16,068,754USD365
2013-07-01 to 2013-09-30-9,325,424USD92
2013-04-01 to 2013-06-30-2,074,035USD91
2013-01-01 to 2013-03-31-1,589,960USD90
2012-10-01 to 2012-12-31-1,988,826USD92
2012-01-01 to 2012-12-31-13,090,446USD366
2012-07-01 to 2012-09-30-2,555,941USD92
2012-04-01 to 2012-06-30-6,928,771USD91
2012-01-01 to 2012-03-311,616,908USD91

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-12-3118,809USD365
2012-01-01 to 2012-12-3111,095USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-10-01 to 2013-12-31434,784USD92
2013-01-01 to 2013-12-311,032,233USD365
2013-07-01 to 2013-09-30253,374USD92
2013-04-01 to 2013-06-30167,668USD91
2013-01-01 to 2013-03-31176,407USD90
2012-10-01 to 2012-12-31430,582USD92
2012-01-01 to 2012-12-311,331,764USD366
2012-07-01 to 2012-09-30264,248USD92
2012-04-01 to 2012-06-30256,407USD91
2012-01-01 to 2012-03-31380,527USD91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-70,155,116USD
At 2012-12-31-54,086,362USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-3126,913USD
At 2012-12-3184,591USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-313,449,650USD365
2012-01-01 to 2012-12-311,280,642USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-16,210,230USD365
2012-01-01 to 2012-12-31-12,432,300USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3116,804,569USD
At 2012-12-3110,403,541USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-3117,538USD365
2012-01-01 to 2012-12-31655,557USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-31992,847USD
At 2012-12-311,256,486USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-3164,434USD
At 2012-12-3169,795USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-10-01 to 2013-12-313,428,793USD92
2013-01-01 to 2013-12-3116,899,109USD365
2013-07-01 to 2013-09-309,465,455USD92
2013-04-01 to 2013-06-302,156,279USD91
2013-01-01 to 2013-03-311,848,582USD90
2012-10-01 to 2012-12-312,014,801USD92
2012-01-01 to 2012-12-3112,885,603USD366
2012-07-01 to 2012-09-302,196,762USD92
2012-04-01 to 2012-06-307,012,848USD91
2012-01-01 to 2012-03-311,661,192USD91

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-31288,383USD
At 2012-12-31124,178USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31688,879USD365
2012-01-01 to 2012-12-31453,303USD366

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-01-01 to 2013-12-317,540,152USD365
2012-01-01 to 2012-12-315,024,616USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-12-319,358,957USD365
2012-01-01 to 2012-12-317,860,987USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3135,993,944shares
At 2012-12-3127,382,830shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-3185,957,757USD
At 2012-12-3163,290,625USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-311,556,549USD
At 2012-12-311,537,740USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-311,529,636USD
At 2012-12-311,453,149USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-12-31175,242USD
At 2012-12-31221,838USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-16,068,754USD365
2012-01-01 to 2012-12-31-13,090,446USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-12-31141,476USD365
2012-01-01 to 2012-12-31-658,146USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-5,679,857USD365
2012-01-01 to 2012-12-31-4,879,978USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-12-3113,804,996USD365
2012-01-01 to 2012-12-3111,888,336USD366
2012-07-29 to 2012-07-3013,000,000USD2

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-5,361USD365
2012-01-01 to 2012-12-31-22,849USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31164,205USD365
2012-01-01 to 2012-12-31-351,414USD366

Inspect the source

Entity
ORAGENICS, INC. / CIK 0001174940
Captured
SEC response SHA-256
8765e20cd543bdc7e794aff6d27b475bcedd0539a650dbf34ce59708a51b55de

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001174940.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))